Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma - An Open-label Randomized Clinical Control Trial in a Tertiary Care Hospital.

NCT05391867 is registered in ClinicalTrials.gov with Sir Salimullah Medical College Mitford Hospital as lead sponsor.

NCT NCT05391867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05391867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma - An Open-label Randomized Clinical Control Trial in a Tertiary Care Hospital.
Lead sponsor
Sir Salimullah Medical College Mitford Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
June 30, 2023
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma